Pre-existing liver disease is associated with poor outcome in patients with SARS CoV2 infection; The APCOLIS Study (APASL COVID-19 Liver Injury Spectrum Study)Shiv Kumar Sarin, Ashok Choudhury, George Lau et al.|Hepatology International|2020Cited by 295
Treatment of chronic hepatitis C in Asia: When East meets WestMing‐Lung Yu, Wan‐Long Chuang|Journal of Gastroenterology and Hepatology|2009Cited by 262
Four‐year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patientsTung‐Hung Su, Jia‐Horng Kao, Chih‐Lin Lin et al.|Liver International|2016Cited by 221
Efficacy of Ledipasvir and Sofosbuvir Treatment of HCV Infection in Patients Coinfected With HBVChun‐Jen Liu, Pei‐Jer Chen, Wan‐Long Chuang et al.|Gastroenterology|2017Cited by 118
2020 Taiwan consensus statement on the management of hepatitis C: Part (II) special populationsMing‐Lung Yu, Wan‐Long Chuang, Pei‐Jer Chen et al.|Journal of the Formosan Medical Association|2020Cited by 98